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1. Introduction 
In hyperphenylalaninemic rats the ratio of mono- 
unsaturated to saturated fatty acids in lipids of whole 
brain and myelin is lower as compared with saline 
treated controls [ 1,2] . In phenylalanine-treated rats 
the rise in cerebral phenylalanine levels is accompanied 
by a rise in the levels of deaminated metabolites of 
phenylalanine, namely phenylpyruvate, phenyllactate 
and phenylacetate [3,4]. Cook and Spence [5] have 
shown that in brain, the supply of mono-unsaturated 
fatty acids is regulated by a desaturation system. Thus, 
the reduction in unsaturated fatty acids in the brains 
of phenylalanine-treated rats could be due to an inter- 
ference with the desaturation process by either phenyl- 
alanine or by one of its metabolite(s). We have there- 
fore investigated the in vitro effects of phenylalanine 
and its metabolites on the desaturation of stearyl CoA 
by preparations from brain tissue. The results indicate 
that the desaturation process is inhibited by phenyl- 
lactate and phenylacetate but not by phenylpyruvate 
and phenylalanine, and thereby suggest hat the reduc- 
tion in the proportion of unsaturated fatty acids in 
the brains of phenylalanine-treated rats is due to in- 
creases in cerebral levels of phenyllactate and phenyl- 
acetate. 
2. Materials and methods 
1-[14C] stearyl CoA (sp. act. 57 mCi/mmol) was 
obtained from New England Nuclear (Boston, Mass.). 
Its radiochemical purity was checked by thin-layer 
chromatography of the methyl ester. Nonradioactive 
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stearyl CoA, stearic acid, oleic acid and NADH were 
purchased from Sigma Chemical Company (St. Louis, 
MO.). Bovine serum albumin (BSA) was purchased 
from Pentex Corporation (Kankakee, Ill.). 
Sprague-Dawley rats (13-20 day-old) were sacri- 
ficed, and the brains were removed, weighed and 
homogenized in 9 vol of 0.32 M sucrose containing 
1 .O mM EDTA. The homogenate was spun at 800 g 
for 10 min, and the resulting supernatant was employ- 
ed as the source of enzyme. Protein content was deter- 
mined by the biuret method 171. Incubation mixtures 
for the assay of stearyl CoA desaturase contained 8 mg 
of enzyme protein, 0.7 mM NADH, 10 mM citrate- 
phosphate buffer (ph 6.4), 0.3 ml of 1% BSA, l-[14C] 
stearyl CoA (100 000 cpm) and 70 /..dvl unlabeled stea- 
ryl CoA in a final vol of 2.0 ml. Incubations were car- 
ried out aerobically with gentle shaking for 15 min at 
37°C. Reactions were terminated by the addition of 
3.0 ml of 15% KOH in 50% ethanol, and the mixtures 
saponified for 20 min at 80°C. Nonsaponifiable lipids 
were extracted with petroleum ether and discarded. 
The aqueous phase was then acidified with 6 N HCl and 
fatty acids extracted twice with petroleum ether. The 
extract containing fatty acids was washed with water, 
dried over anhydrous sodium sulfate, and the solvent 
was evaporated under nitrogen. The fatty acids were 
methylated with 10% BF3 in methanol and the resul- 
ting methyl esters were separated by thin-layer chroma- 
tography on silver nitrate impregnated silica gel H as 
described by Morrison and Smith [8]. The spots were 
visualized under ultraviolet light after spraying with a 
0.5% solution of Rhodamine 6G in ethanol. R, values 
for methyl stearate and methyl oleate in this system 
were 0.90 and 0.50, respectively. The areas correspon- 
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ding to the respective methyl esters were scraped and 
the esters were eluted twice with ethyl ether. The 
[ l4 C] content in the ester fractions was assayed by 
using a liquid scintillation spectrometer. The amount 
of stearyl CoA desaturated was calculated from the 
radioactivity recovered from the region of the chroma- 
togram containing the methyl oleate. Gas liquid chro- 
matography of the material from this region gave the 
major peak corresponding to C,,:r and a small peak 
corresponding to C2uZ1. 
3. Results and discussion 
Initial studies indicated that desaturation of stearyl 
CoA was linear up to 20 min of incubation, and was 
optimal at 100 /.&I stearyl CoA. The amount of stearyl 
CoA desaturated increased in proportion to an increase 
in supernatant protein concentration of up to 10 mg. 
The results presented in table 1 show that phenyllac- 
tate and phenylacetate inhibited the desaturation of 
stearyl CoA by 5% at concentrations of 3 mM. On 
the other hand, phenylalanine and phenylpyruvate 
even at concentrations as high as 5 mh4 had little or 
no effect on the reaction. We next examined the effect 
of phenyllactate and phenylacetate at varying concen- 
trations on the desaturation of stearyl CoA. The inhi- 
bition was proportional to the inhibitor concentrations 
Table 1 
Effects of phenylalanine and its metabolites on desaturation 
of stearyl CoA by 800 g (10 min) supematant from rat brain 
Additions Stearyl CoA desaturated 
% of 
p mol/mg protein/mm Control 
None 40.2 100 
Phenylalanine (3 mM) 36.0 89.4 
,, 
(5 mM) 35.4 88.1 
Phenylpyruvate (3 mM) 36.4 90.5 
>, (5 mM) 35.6 88.6 
Phenyllactate (3 mM) 17.0 42.2 
Phenylacetate (3 mM) 13.8 34.4 
The details of the assay conditions are given in text. The 
solutions of inhibitors were adjusted to pH 6.4 with 1 M NaOH 
prior to their additions to the incubation mixtures. The results 
of a typical experiment are presented in the table. Each value 
is an average of closely agreeing duplicate determinations. 
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Fig.1. Inhibition of stearyl CoA desaturation as a function of 
inhibitor concentration. The details of assay conditions are 
described in text. The solutions of phenylacetate and phenyl- 
lactate were adjusted to pH 6.4 with 1 M NaOH prior to their 
addition to the incubation mixture. VO and v are the uninhi- 
bited and inhibited rates of reaction respectively. The calculat- 
ed value for the slope as a function of phenyllactate is 1.9 1, 
and that of phenylacetate is 2.0. Each plotted point is an ave- 
rage of closely agreeing duplicate determinations. (-) 
phenyllactate, (X -X -x) phenylacetate. 
over the range of 1 to 5 mM. Hill type plots of the 
inhibition (fig.1) by phenyllactate and phenylacetate 
were linear with slope values of 1.9 1 and 2.00, respec- 
tively, suggesting a second order interaction between 
the inhibitor molecules and the desaturase system at 
a single rate limiting step [9] . 
In brain tissue, as in other animal tissues, desatura- 
tion of stearyl CoA requires molecular oxygen and 
reduced pyridine nucleotide. Phenylacetate does not 
inhibit oxygen utilization by brain mitochondria [lo] , 
thus the site of inhibition is not associated with the 
reaction(s) utilizing molecular oxygen. In view of the 
similarities in the kinetics of phenylacetate and phenyl- 
lactate inhibition we would presume their mechanism 
of inhibition to be similar. 
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The results of the present study show that phenyl- 
lactate and phenylacetate added in vitro inhibit the 
desaturation of stearyl CoA but that phenylalanine 
added in vitro has no effect in the reaction. The cere- 
bral levels of these metabolites are elevated, in phenyl- 
alanine-treated rats, and in genetic phenylketonuria. 
Although the concentrations of phenyllactate and 
phenylacetate required for in vitro inhibition of the 
desaturase are considerably higher than the concen- 
trations likely to be encountered in in vivo situations, 
prolonged exposure of the brain tissue to these meta- 
bolites may result in in vivo inhibition of stearyl CoA 
desaturase. This in turn would cause a reduction in 
monounsaturated fatty acids. Such a reduction has 
indeed been observed in brain tissue of rats subjected 
to chronic hyperphenylalaninemia [ 1,2] and in brains 
from phenylketonuric individuals [ 1 l- 131. 
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